Enanta Pharma (ENTA) Announces Positivei Data from VIEKIRAX + EXVIERA Regiment in GT1 HCV (ABBV)
Tweet Send to a Friend
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) announced data showing that patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
